Literature DB >> 16644229

Senataxin, the yeast Sen1p orthologue: characterization of a unique protein in which recessive mutations cause ataxia and dominant mutations cause motor neuron disease.

Ying-Zhang Chen1, Sayed H Hashemi, Susan K Anderson, Yongzhao Huang, Maria-Ceu Moreira, David R Lynch, Ian A Glass, Phillip F Chance, Craig L Bennett.   

Abstract

A severe recessive cerebellar ataxia, Ataxia-Oculomotor Apraxia 2 (AOA2) and a juvenile onset form of dominant amyotrophic lateral sclerosis (ALS4) result from mutations of the Senataxin (SETX) gene. To begin characterization this disease protein, we developed a specific antibody to the DNA/RNA helicase domain of SETX. In murine brain, SETX concentrates in several regions, including cerebellum, hippocampus and olfactory bulb with a general neuronal expression profile, colocalizing with NeuN. In cultured cells, we found that SETX was cytoplasmically diffuse, but in the nucleus, SETX was punctate, colocalizing with fibrillarin, a marker of the nucleolus. In differentiated non-cycling cells, nuclear SETX was not restricted to the nucleolus but was diffuse within the nucleoplasm, suggesting cell-cycle-dependent localization. SETX missense mutations cluster within the N-terminus and helicase domains. Flag tagging at the N-terminus caused protein mislocation to the nucleoplasm and failure to export to the cytoplasm, suggesting that the N-terminus may be essential for correct SETX localization. We report here the first characterization of SETX protein, which may provide future insights into a new mechanism leading to neuron death.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16644229     DOI: 10.1016/j.nbd.2006.02.007

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  43 in total

Review 1.  RNA processing pathways in amyotrophic lateral sclerosis.

Authors:  Marka van Blitterswijk; John E Landers
Journal:  Neurogenetics       Date:  2010-03-27       Impact factor: 2.660

2.  Transcription termination by nuclear RNA polymerases.

Authors:  Patricia Richard; James L Manley
Journal:  Genes Dev       Date:  2009-06-01       Impact factor: 11.361

Review 3.  Epigenetic principles and mechanisms underlying nervous system functions in health and disease.

Authors:  Mark F Mehler
Journal:  Prog Neurobiol       Date:  2008-10-17       Impact factor: 11.685

Review 4.  DNA damage and repair: relevance to mechanisms of neurodegeneration.

Authors:  Lee J Martin
Journal:  J Neuropathol Exp Neurol       Date:  2008-05       Impact factor: 3.685

5.  Mutation of senataxin alters disease-specific transcriptional networks in patients with ataxia with oculomotor apraxia type 2.

Authors:  Brent L Fogel; Ellen Cho; Amanda Wahnich; Fuying Gao; Olivier J Becherel; Xizhe Wang; Francesca Fike; Leslie Chen; Chiara Criscuolo; Giuseppe De Michele; Alessandro Filla; Abigail Collins; Angelika F Hahn; Richard A Gatti; Genevieve Konopka; Susan Perlman; Martin F Lavin; Daniel H Geschwind; Giovanni Coppola
Journal:  Hum Mol Genet       Date:  2014-04-23       Impact factor: 6.150

6.  Ataxia with oculomotor apraxia type 2 fibroblasts exhibit increased susceptibility to oxidative DNA damage.

Authors:  Ricardo H Roda; Carlo Rinaldi; Rajat Singh; Alice B Schindler; Craig Blackstone
Journal:  J Clin Neurosci       Date:  2014-05-06       Impact factor: 1.961

7.  Novel mutations in ataxia telangiectasia and AOA2 associated with prolonged survival.

Authors:  Marie Y Davis; C Dirk Keene; Phillip D Swanson; Conor Sheehy; Thomas D Bird
Journal:  J Neurol Sci       Date:  2013-09-17       Impact factor: 3.181

8.  Biochemical and genetic evidence for a role of IGHMBP2 in the translational machinery.

Authors:  Mariàngels de Planell-Saguer; David G Schroeder; Maria Celina Rodicio; Gregory A Cox; Zissimos Mourelatos
Journal:  Hum Mol Genet       Date:  2009-03-19       Impact factor: 6.150

Review 9.  DNA repair deficiency and neurological disease.

Authors:  Peter J McKinnon
Journal:  Nat Rev Neurosci       Date:  2009-01-15       Impact factor: 34.870

10.  Aberrant splicing of the senataxin gene in a patient with ataxia with oculomotor apraxia type 2.

Authors:  Brent L Fogel; Ji Yong Lee; Susan Perlman
Journal:  Cerebellum       Date:  2009-12       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.